Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer

CONCLUSIONS: the results of this study showed the promising survival outcomes in patients with genotype-matched therapy under public insurance, even in the castration-resistant prostate cancer setting. Further detection of promising therapeutic target gene is expected to increase the number of patients who reach genotype-matched therapies.PMID:38305663 | DOI:10.1093/jjco/hyae003

Source: Clinical Prostate Cancer - February 2, 2024 Category: Cancer & Oncology Authors: Dai Koguchi Hideyasu Tsumura Ken-Ichi Tabata Soichiro Shimura Takefumi Satoh Masaomi Ikeda Akinori Watanabe Tsutomu Yoshida Jiichiro Sasaki Kazumasa Matsumoto Masatsugu Iwamura Source Type: research